【24h】

Thalidomide halts capillary growth in embryonic limb buds

机译:沙利度胺可阻止胚胎肢芽中的毛细血管生长

获取原文
获取原文并翻译 | 示例
           

摘要

Thalidomide, once commonly prescribed to prevent vomiting in pregnant women, was withdrawn after it was found to cause birth defects. The medication, however, has been used selectively as an anticancer drug since that time because of its abilityrnto suppress growth of new blood vessels, which makes it potent against tumors. But thalidomide has many breakdown products in the body and it is not clear which ones are responsible for antiangio-genesis-nor have researchers been able to explain exactly how thalidomide causes birth defects.
机译:沙利度胺曾经被普遍处方用于预防孕妇呕吐,但在发现会导致先天缺陷后撤出。但是,从那时候起,该药物就被选择性地用作抗癌药物,因为它具有抑制新血管生长的能力,这使其对肿瘤有效。但是,沙利度胺在体内具有多种分解产物,尚不清楚哪些是抗血管生成的原因,研究人员也无法确切解释沙利度胺如何导致出生缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号